Light‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin
Advanced Healthcare Materials · 2025-06 · 14 (15)
DOI: 10.1002/adhm.202500589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 18.04.2025. Verfasst von Giuseppe Longobardi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, I-80131, Italy. Hauptthemen laut MEDLINE: Hyaluronic Acid, Nitric Oxide, Skin, Light. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Hyaluronic acid (HA), renowned for its hydrating properties, penetrates deeper into the skin at a very low molecular weight, promoting cellular repair and reducing inflammation. Nitric oxide (NO), a gaseous mediator with a very relevant role in many physiological and pathophysiological processes, is expected to complement the functions of HA in the skin through its vasodilatory, anti‐inflammatory, and regenerative properties. Herein, a novel class of HA derivatives functionalized with NO photodonors (NOPD) for light‐activated therapeutic applications is introduced. The HA derivatives HA‐NOPD1 and HA‐NOPD2 demonstrated NO release under blue light activation. Biological assays on HaCaT keratinocytes revealed enhanced proliferation and migration under light stimuli, underscoring the therapeutic potential of HA‐NOPD1. The derivatives are formulated into microemulsions (MEs) to allow their skin transport. MEs loaded with the photoresponsive derivatives are stable in the dark and provide effective NO photorelease with higher quantum yields than the free compounds. Skin permeation studies using porcine and artificial membranes confirmed that HA‐NOPD2 distributed in all the skin layers, reaching the dermis and releasing NO in situ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, I-80131, Italy.
- PhotoChemLab, Department of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, Catania, I-95125, Italy.
- Institute for Polymers, Composites and Biomaterials (IPCB)-CNR, Via Campi Flegrei 34, Pozzuoli, I-80078, Italy.
ORCID-Profile: Giuseppe Longobardi, Cristina Parisi, Ovidio Catanzano, Anna Di Porzio, Antonio Randazzo, Salvatore Sortino, Fabiana Quaglia
Förderung
- Ministero dell'Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Longobardi, G., Parisi, C., Sodano, F., Catanzano, O., Porzio, A. D., Randazzo, A., Sortino, S., & Quaglia, F. (2025). Light‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin. Advanced Healthcare Materials, 14(15). https://doi.org/10.1002/adhm.202500589
Vancouver
Longobardi G, Parisi C, Sodano F, Catanzano O, Porzio AD, Randazzo A, et al. Light‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin. Advanced Healthcare Materials. 2025;14(15). doi:10.1002/adhm.202500589
BibTeX
@article{Longobardi2025,
author = {Longobardi, Giuseppe and Parisi, Cristina and Sodano, Federica and Catanzano, Ovidio and Porzio, Anna Di and Randazzo, Antonio and Sortino, Salvatore and Quaglia, Fabiana},
title = {Light‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {15},
doi = {10.1002/adhm.202500589}
}
EUVIMED